As of 28 Aug 2026, Mahamaya Lifesciences Ltd share price is ₹183.00. The stock opened at ₹183.00 and had closed at ₹195.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹111.00 and a high of ₹205.05. In terms of performance, Mahamaya Lifesciences Ltd share price has increased by 18.99% over the past six months and has increased by 68.53% over the last year.
Mahamaya Lifesc. Charts
Mahamaya Lifesciences Ltd Overview
About Mahamaya Lifesc.
Mahamaya Lifesciences specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
Mahamaya Lifesciences Ltd Historical Performance
Mahamaya Lifesciences Ltd Fundamental Analysis
Mahamaya Lifesciences Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Mahamaya Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 67.22 |
| MACD | 7.13 |
| 20-Day SMA | 183.73 |
Mahamaya Lifesciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Mahamaya Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| UPL LtdUPL | ₹578.10-1.90% | ₹51,802.16 | 25.84 | 5.54% |
| P I Industries LtdPIIND | ₹2,467.00-1.65% | ₹46,368.09 | 31.96 | 11.76% |
| Sumitomo Chemical India LtdSUMICHEM | ₹525.00-1.03% | ₹19,746.21 | 37.15 | 16.02% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Mahamaya Lifesciences Ltd today is ₹183.00 on NSE and ₹183.00 on BSE.
- The 52-week high of Mahamaya Lifesciences Ltd is ₹205.05, while the 52-week low is ₹111.00.
- The current market capitalisation of Mahamaya Lifesciences Ltd is approximately ₹458 crore.
- The P/E (Price-to-Earnings) ratio of Mahamaya Lifesciences Ltd is 28.75. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Mahamaya Lifesciences Ltd is 3.27. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Mahamaya Lifesciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Mahamaya Lifesciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Mahamaya Lifesciences Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Mahamaya Lifesciences Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 56.35% promoters, 4.77% FIIs, 2.52% DIIs, and 10.65% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
